These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8970747)

  • 1. Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat.
    Fukuhara A; Imai T; Otagiri M
    Chirality; 1996; 8(7):494-502. PubMed ID: 8970747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
    Imai T; Fukuhara A; Ueda I; Otagiri M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):328-33. PubMed ID: 8097246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral multiple-dose administration of anti-inflammatory flurbiprofen chimera drug on gastric lesion, other toxicities and disposition kinetics.
    Fukuhara A; Imai T; Inoue K; Otagiri M
    Biol Pharm Bull; 1995 Jan; 18(1):140-7. PubMed ID: 7735229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the pharmacokinetic and pharmacodynamic properties of a drug by chemical conversion to a chimera drug.
    Otagiri M; Imai T; Fukuhara A
    J Control Release; 1999 Nov; 62(1-2):223-9. PubMed ID: 10518654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats.
    Nagao T; Tanino T; Iwaki M
    Chirality; 2003 May; 15(5):423-8. PubMed ID: 12692887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and the stereoselective enzymatic hydrolysis of flurbiprofen-basic amino acid ethyl esters.
    Tsunematsu H; Yoshida S; Horie K; Yamamoto M
    J Drug Target; 1995; 2(6):517-25. PubMed ID: 7773614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues.
    Takahashi K; Tamagawa S; Sakano H; Katagi T; Mizuno N
    Biol Pharm Bull; 1995 Oct; 18(10):1401-4. PubMed ID: 8593445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vivo pharmacokinetic behaviors of R- and S-flurbiprofen after intravenous injection of flurbiprofen axetil.
    He Y; Qin M; Li M; Zhi D; Tian B; Qin F
    Chirality; 2023 Apr; 35(4):247-255. PubMed ID: 36759185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
    Ahmed S; Imai T; Yoshigae Y; Otagiri M
    Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective pharmacokinetics of flobufen in rats.
    Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
    Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
    Ahmed S; Imai T; Otagiri M
    Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
    Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
    Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of flurbiprofen in man: influence of stereochemistry and age.
    Patel BK; Jackson SH; Swift CG; Hutt AJ
    Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective enzymatic hydrolysis of various ester prodrugs of ibuprofen and flurbiprofen in human plasma.
    Mørk N; Bundgaard H
    Pharm Res; 1992 Apr; 9(4):492-6. PubMed ID: 1495894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
    Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
    Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in rat tissue homogenates.
    Takahashi K; Tamagawa S; Haginaka J; Yasuda H; Katagi T; Mizuno N
    J Pharm Sci; 1992 Mar; 81(3):226-7. PubMed ID: 1640358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.